Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

DRAC vs. MSOS: which is better?

Bottom line

DRAC vs MSOS: the short answer

DRAC (GraniteShares Autocallable DRAM ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.

Updated Nov 19, 2026

DRAC vs MSOS side by side

DRACMSOS
TypeETFETF
Fund familyGraniteshares Autocallable DramAdvisorshares
CategoryOtherOther
Expense ratio—0.78%
Annual cost per $10k—$78
10-yr cost on $10k (prospectus)—$927
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+23.4%
5-yr return (annualized)—−33.6%
10-yr return (annualized)——
Best quarter—+102.2%
Worst quarter—−50.4%
Net assets (fund)—$1.0B
Number of holdings—61
Portfolio turnover—5%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

DRAC and MSOS share none of their top holdings.

DRAC top 10

    MSOS top 10

    1. Curaleaf Holdings Inc — 12.32%
    2. Trulieve Cannabis Corp — 9.56%
    3. Blackrock Treasury Trust — 5.78%
    4. Terrascend Corp — 2.70%
    5. Marex Capital Markets Inc. — 2.16%
    6. Cantor Fitzgerald & Co. — 1.08%
    7. Morgan Stanley & Co. Llc — 0.94%
    8. Glass House Brands Inc — 0.93%
    9. Nomura Securities International, Inc. — 0.85%
    10. Cantor Fitzgerald & Co. — 0.78%

    FAQ

    What is the difference between DRAC and MSOS?
    DRAC (GraniteShares Autocallable DRAM ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.
    Should I own both DRAC and MSOS?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.